Q: What is your opinion of this company? Thank you
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Would appreciate your comments on recent pullback. A small earnings miss and then buy back of shares at $99. Is this an opportunity to add to a 2% position? Thanks
Q: Dearr 5i
What are the expected earnings growth rates for AMAT , AMD and NVDA over the next 1-2 years and which would you recommend for an RRSP assuming a balanced portfolio .
Thanks
Bill C.
What are the expected earnings growth rates for AMAT , AMD and NVDA over the next 1-2 years and which would you recommend for an RRSP assuming a balanced portfolio .
Thanks
Bill C.
Q: I just received an email from Citron talking about SDGR. They feel it is the second coming of TSLA but of course, in a different industry.
They are a brand new IPO and are up 20% today, but would this be worth purchasing in the event that it pulls back to prior to the letter and held for a period of time.
In a nutshell they recap it thusly:
"Through use of artificial intelligence and a world class scientific team that is unmatched by ANY public company, Schrodinger has created a software platform that integrates predictive physics-based methods with machine learning to become the leader in molecular simulation that 1) reduces the average time and cost required to identify a drug development candidate and 2) increases the probability of drug discovery programs entering clinical development.
With the global pharma industry spending approximately $180 billion on R&D annually, this innovative software platform is completely disrupting the drug development process."
Would you invest in this concept yourselves, once you research more about it.? I know its not a p/e , value play it may or may not be TSLA of 10 years ago.
Thanks
Sheldon
They are a brand new IPO and are up 20% today, but would this be worth purchasing in the event that it pulls back to prior to the letter and held for a period of time.
In a nutshell they recap it thusly:
"Through use of artificial intelligence and a world class scientific team that is unmatched by ANY public company, Schrodinger has created a software platform that integrates predictive physics-based methods with machine learning to become the leader in molecular simulation that 1) reduces the average time and cost required to identify a drug development candidate and 2) increases the probability of drug discovery programs entering clinical development.
With the global pharma industry spending approximately $180 billion on R&D annually, this innovative software platform is completely disrupting the drug development process."
Would you invest in this concept yourselves, once you research more about it.? I know its not a p/e , value play it may or may not be TSLA of 10 years ago.
Thanks
Sheldon
Q: Do you have a view on this company. Many years ago in a previous job I dealt with them extensively but do not recall them pushing their public company status. My experince was they tended to regularly buy out rising competitors. Looking for analysis of the key metrics.
Q: Do you have a preference here or do you prefer a different semi conductor ETF? Tha nks
Q: Looking to increase my American technology positions. I'm interested in taking a position in Adobe. What do you think the future holds for this company, short term, (1 year) and long term (5 years). I'm trying to decide between ADBE and MSFT. Which do you think is the best investment or would you buy both? Would they complement each other? Are there other U.S. tech. companies you like as well or better?
Q: I'm a big fan of tech.
NVDA was my first chips play. The semis look very cyclical.
So I almost have a double with NVDA.
Not sure whether to take some off, half off.
I don't think that this is going to do a SHOP or a TSLA.
Your thoughts please.
Mark
NVDA was my first chips play. The semis look very cyclical.
So I almost have a double with NVDA.
Not sure whether to take some off, half off.
I don't think that this is going to do a SHOP or a TSLA.
Your thoughts please.
Mark
Q: SHOP is almost 30% of this ETF now. Shouldn't the "manager" be adjusting the weightings of this Fund? I realize it's slim pickings in the Cdn Tech sector but the other holdings could be beefed up and SHOP could be shaved back a bit. With a bad Q, SHOP could drag this ETF thru the mud.
-
Applied Materials Inc. (AMAT)
-
Intel Corporation (INTC)
-
Advanced Micro Devices Inc. (AMD)
-
Taiwan Semiconductor Manufacturing Company Ltd. (TSM)
Q: IWish to get a position in this area of the tech space,and would appreciate your input as to the best of the group.
Doug
Doug
Q: Hello 5i l read on moltey fool where bb & Amazon partnered up just wondering what you thought of this thx Kim
Q: I have neither Telaria or Rubicon Proj. but I would like to start a position. With the merger between them how would you play this? Buy both before the merger or buy one and why. What happens after the merger? Do you think the merger makes good sense ?
Thanks, Peter
Thanks, Peter
Q: What does the bought deal mean to the shareholders in short, medium and long term.
Clayton
Clayton
Q: Morning guys:
What are your thoughts of this name? Is it to late to start a position ?
Thank u
Mark
What are your thoughts of this name? Is it to late to start a position ?
Thank u
Mark
Q: Hi 5iR Team, Solar power generation, installation, technology, etc., anything to do with solar power, can you list a few Can/US notable companies for me? Thanks Team. Cheers, Chris
Q: I’m looking at starting a position in SYZ to go along my holdings of IBM and Cisco, can I have your thoughts?
Q: I have held Cisco for many a year and I am up. Lately it seems to going nowhere but it is a top pick for many. What are your thoughts. Would it be a sell and purchase ROKU.
As always,
Regards
As always,
Regards
Q: Your recent report on KXS notes that the expected F2020 revenue growth is 11.1% and a CIBC report forecasts revenue growth of 17% in F2021. Both these estimates are below the expected F2019 revenue growth of 26% and lower than the 22.4% forecasted annual growth rate (to 2022) of the SaaS application market in supply chain management. In such a competitive market, forecasts of declines in revenue growth and forecasted growth which is lower than the market’s growth are not ideal signs and something to monitor. Have you picked up any explanations for the decline in forecasted revenue growth in F2020 and the overall choppiness of revenue growth?
Q: what is your opinion of facedrive.
seems to be 90,000 ,000 shares outstanding, is that right
would you own it.
dave
seems to be 90,000 ,000 shares outstanding, is that right
would you own it.
dave
Q: Any thoughts on why this one is shit*%ng the proverbial bed after surprising to the upside? Like winning first prize but the reward is a kick in the groin.